Pharmacogenetics and the treatment of HIV-/HCV-coinfected patients-Reference-Cited by-同舟云学术

Pharmacogenetics and the treatment of HIV-/HCV-coinfected patients

Published:2018-08-01 Issue:12 Volume:19 Page:979-995
ISSN:1462-2416
Container-title:Pharmacogenomics
language:en
Short-container-title:Pharmacogenomics

Author:

Frias Mario¹,Rivero-Juárez Antonio¹,López-López Pedro¹,Rivero Antonio¹

Affiliation:

1. Department of Clinical Virology & Zooneses, Hospital Universitario Reina Sofía de Córdoba, Instituto Maimonides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba. Córdoba, 14004, Spain

Abstract

This review will summarize the role of pharmacogenetics in the natural history of hepatitis C, particularly in patients with HIV/HCV and will take the perspective of pharmacogenetics and its influence on the response to antiviral therapy and the susceptibility to develop adverse effects. This review will also devote a section to host genetics in other clinical situations, such as disease progression and acute HCV infection, which may determine whether treatment of HIV-/HCV-coinfected patients is implemented or deferred.

Publisher

Future Medicine Ltd

Subject

Pharmacology,Genetics,Molecular Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/pgs-2018-0046

Reference170 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

2. Global elimination of hepatitis C virus infection: Progresses and the remaining challenges

3. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis

4. Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta‐Analysis

5. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomic Profile of Amazonian Amerindians;Journal of Personalized Medicine;2022-06-10

2. HCV Seroprevalence among HIV Patients and Associated Comorbidities at One Primary Health Facility in Rwanda;The American Journal of Tropical Medicine and Hygiene;2021-05-05